Total raised
$204.0M
Last: Series C 2023-07
Stage
Series C
Founded
2009
Headcount
3
HQ
Caesarea
Sector
Health Tech & Life Sciences
About
MitrAssist has developed an approach to treating patients with life-threatening mitral regurgitation (MR) that involves neither repair nor replacement. Instead, the companys proprietary valve implant is placed on top of the natural valve to work in unison with it and to enhance valve functionality. MitrAssists valve-in-valve approach overcomes the various challenges of MR and offers an alternative treatment solution for all MR patients. Made from biomedical and biological materials, MitrAssists valve offers improved biocompatibility and patient recovery time.
Funding history · 5 rounds · $204.0M total
2023-07
Series C
$100.0M
2020-12
Series B
$70.0M
2017-11
Series A
$30.0M
2014-01
Series A
$3.0M
2013-07
Seed
$1.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is MitrAssist's core medical technology?
- MitrAssist developed a proprietary valve implant for treating mitral regurgitation (MR). This implant is designed to be placed on top of the natural valve to enhance its functionality, rather than repairing or replacing it.
- When was MitrAssist founded?
- MitrAssist was founded in April 2009.
- What is the current operational status of MitrAssist?
- MitrAssist is currently inactive and ceased to operate in January 2026.
- Where is MitrAssist headquartered?
- MitrAssist is headquartered in Caesarea, Israel.
- When did MitrAssist raise its Series C funding round and who were the lead investors?
- In July 2023, MitrAssist closed a Series C funding round with Centurium Capital and 6 Dimension Capital as lead investors.
- Which investors participated in MitrAssist's Series B funding round?
- MitrAssist's Series B round in December 2020 included Centurium Capital, Fosun Pharma, Ping An Ventures, 6 Dimension Capital, CITIC Capital, and CICC Capital.
- What was the total amount raised by MitrAssist across all funding rounds?
- MitrAssist raised a total of $204,000,000 across all its funding rounds.
- What is the product stage of MitrAssist's technology?
- MitrAssist's product is in the clinical trial stage.
- How many employees did MitrAssist have?
- MitrAssist had between 1 and 10 employees, with an exact count of 3.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
cardiologyhospitalsdoctorsbiomaterialssurgerymedical-devicesvalvesminimally-invasive